Literature DB >> 23551976

Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California.

R S Lo1, A Ribas, G V Long, R Ballotti, M Berger, H Willy, G T Gibney, M Bosenberg, E Bernstein, J Villanueva, K S M Smalley.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23551976     DOI： 10.1111/pcmr.12103

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  3 in total

1.  New combinations and immunotherapies for melanoma: latest evidence and clinical utility.

Authors:  Alexander M Menzies; Georgina V Long
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

2.  Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.

Authors:  Hubing Shi; Willy Hugo; Xiangju Kong; Aayoung Hong; Richard C Koya; Gatien Moriceau; Thinle Chodon; Rongqing Guo; Douglas B Johnson; Kimberly B Dahlman; Mark C Kelley; Richard F Kefford; Bartosz Chmielowski; John A Glaspy; Jeffrey A Sosman; Nicolas van Baren; Georgina V Long; Antoni Ribas; Roger S Lo
Journal:  Cancer Discov       Date:  2013-11-21       Impact factor: 39.397

3.  A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.

Authors:  Hubing Shi; Aayoung Hong; Xiangju Kong; Richard C Koya; Chunying Song; Gatien Moriceau; Willy Hugo; Clarissa C Yu; Charles Ng; Thinle Chodon; Richard A Scolyer; Richard F Kefford; Antoni Ribas; Georgina V Long; Roger S Lo
Journal:  Cancer Discov       Date:  2013-11-21       Impact factor: 39.397
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.